Newron Pharmaceuticals has seen a much needed quick turnaround for its lead Parkinson’s drug as it can now resubmit its candidate in the U.S.--just four months…

Seattle startup Just Biotherapeutics has nabbed another $14 million to work on affordable biologics with a team lifted from Amgen as well as major backing…

Tobira Therapeutics fell by about half in premarket trading on news that its Phase IIb trial to treat nonalcoholic steatohepatitis (NASH) failed to meet the…

As the world’s top researchers working in Alzheimer’s disease descend into Toronto for the AAIC this week, all will be coming with a continued show of hope--…

Bristol-Myers Squibb will team up with AbbVie to run an early-stage lung cancer study combining BMS’ marketed checkpoint inhibitors with AbbVie’s experimental…

The FDA has designated Morphochem’s MCB3837 as a Qualified Infectious Disease Product and simultaneously put the antibiotic on its regulatory fast-track…

Biogen's CEO steps down, Theranos brings on a team to right its wrongs and FDA's Hall leaves for PatientsLikeMe. Plus more hirings, firings and…

The FDA is not happy with Merck’s monoclonal antibody Clostridium difficile candidate and is demanding more data and analyses from its trials before it can…